Synthesis and evaluation of platelet aggregation inhibitory activity of some 3-phenyl-pyrroloquinazolinones.

作者: Maria Grazia Ferlin , Christian Borgo , Renzo Deana

DOI: 10.1016/J.EJMECH.2011.12.026

关键词:

摘要: A series of 3-phenyl-2,7-dihydro-1H-pyrrolo[3,2-f]quinazolin-1-one derivatives (3-PPyQZ) was synthesized starting from 5-amino-indoles, via condensation with N-ethoxycarbonylthiobenzamides followed by thermal cyclization. On the basis their structural analogy reported anti-thrombin pyrroloquinazolines, were first tested for capacity to inhibit platelet aggregation. Some them had in vitro inhibitory effects on collagen and thrombin-induced aggregation in micromolar range, much higher inhibition than that shown some phenyl-pyrroloquinolinones. Experiments determine mechanism action most potent inhibitor (compound 18) indicated it acts at least two sites: one preceding agonist-induced increase cytosolic [Ca(2+)], following this step activation cascade. The compound also inhibited thrombin-evoked protein-Tyr-phosphorylation. Although is premature draw definitive conclusions, present results indicate 3-PPyQZ structure, quite 18, might constitute a point synthesis potential anti-thrombosis agents.

参考文章(42)
Shradha Sinha, Mukta Srivastava, Biologically active quinazolones. Progress in drug research. ,vol. 43, pp. 143- 238 ,(1994) , 10.1007/978-3-0348-7156-3_5
W Siess, Molecular mechanisms of platelet activation. Physiological Reviews. ,vol. 69, pp. 58- 178 ,(1989) , 10.1152/PHYSREV.1989.69.1.58
V. Alagarsamy, V. Raja Solomon, K. Dhanabal, Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H-quinazolin-4-one as analgesic, anti-inflammatory agents. Bioorganic & Medicinal Chemistry. ,vol. 15, pp. 235- 241 ,(2007) , 10.1016/J.BMC.2006.09.065
Maria Grazia Ferlin, Maria Teresa Conconi, Luca Urbani, Barbara Oselladore, Diego Guidolin, Rosa Di Liddo, Pier Paolo Parnigotto, Synthesis, in vitro and in vivo preliminary evaluation of anti-angiogenic properties of some pyrroloazaflavones. Bioorganic & Medicinal Chemistry. ,vol. 19, pp. 448- 457 ,(2011) , 10.1016/J.BMC.2010.11.010
W. D. Dean, E. P. Papadopoulos, N-ethoxycarbonylamidines as starting materials and intermediates in the synthesis of heterocyclic compounds Journal of Heterocyclic Chemistry. ,vol. 19, pp. 171- 176 ,(1982) , 10.1002/JHET.5570190133
A. Golden, J. S. Brugge, Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 901- 905 ,(1989) , 10.1073/PNAS.86.3.901
Ho-Sam Ahn, Leyla Arik, George Boykow, Duane A. Burnett, Mary Ann Caplen, Michael Czarniecki, Martin S. Domalski, Carolyn Foster, Mahua Manna, Andrew W. Stamford, Yusheng Wu, Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. ,vol. 9, pp. 2073- 2078 ,(1999) , 10.1016/S0960-894X(99)00339-X
Stephen A Back, Ruhi Khan, Xiadong Gan, Paul A Rosenberg, Joseph J Volpe, A new Alamar Blue viability assay to rapidly quantify oligodendrocyte death Journal of Neuroscience Methods. ,vol. 91, pp. 47- 54 ,(1999) , 10.1016/S0165-0270(99)00062-X
Franco Zoccarato, Maria Ruzzene, Lucia Cavallini, M. Grabriella Doni, Maria Angela Francesconi, Renzo Deana, Adolfo Alexandre, Platelet responses promoted by the activation of protein kinase C or the increase of cytosolic Ca2+ are potentiated by adrenaline. Effects of cAMP and staurosporine Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. ,vol. 1092, pp. 72- 78 ,(1991) , 10.1016/0167-4889(91)90178-Z